- Home
- GLDG vs EDIT Comparison
GLDG vs EDIT Comparison
Compare GLDG & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDG
- EDIT
- Stock Information
- Founded
- GLDG 2009
- EDIT 2013
- Country
- GLDG Canada
- EDIT United States
- Employees
- GLDG N/A
- EDIT N/A
- Industry
- GLDG Precious Metals
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLDG Basic Materials
- EDIT Health Care
- Exchange
- GLDG Nasdaq
- EDIT Nasdaq
- Market Cap
- GLDG 317.0M
- EDIT 269.8M
- IPO Year
- GLDG N/A
- EDIT 2016
- Fundamental
- Price
- GLDG $1.41
- EDIT $3.65
- Analyst Decision
- GLDG Strong Buy
- EDIT Buy
- Analyst Count
- GLDG 2
- EDIT 11
- Target Price
- GLDG $3.50
- EDIT $4.56
- AVG Volume (30 Days)
- GLDG 4.4M
- EDIT 3.2M
- Earning Date
- GLDG 10-10-2025
- EDIT 10-31-2025
- Dividend Yield
- GLDG N/A
- EDIT N/A
- EPS Growth
- GLDG N/A
- EDIT N/A
- EPS
- GLDG N/A
- EDIT N/A
- Revenue
- GLDG N/A
- EDIT $38,901,000.00
- Revenue This Year
- GLDG N/A
- EDIT N/A
- Revenue Next Year
- GLDG N/A
- EDIT N/A
- P/E Ratio
- GLDG N/A
- EDIT N/A
- Revenue Growth
- GLDG N/A
- EDIT N/A
- 52 Week Low
- GLDG $0.71
- EDIT $0.91
- 52 Week High
- GLDG $1.80
- EDIT $4.54
- Technical
- Relative Strength Index (RSI)
- GLDG 49.85
- EDIT 51.73
- Support Level
- GLDG $1.38
- EDIT $3.48
- Resistance Level
- GLDG $1.71
- EDIT $4.27
- Average True Range (ATR)
- GLDG 0.13
- EDIT 0.38
- MACD
- GLDG -0.03
- EDIT -0.06
- Stochastic Oscillator
- GLDG 27.10
- EDIT 28.34
About GLDG GoldMining Inc.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; Crucero project, located in Peru; Sao Jorge, Batistao, located in Brazil; Yellowknife Gold Project, located in the Northwest Territories, Canada; and various other projects such as Cachoeira, Yarumalito, Whistler, Surubim, Montes Aureos and Trinta, Rea across different locations. The company has two operating segments, with U.S. GoldMining being one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.